Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.

about

Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.

Item

http://www.wikidata.org/entity/Q38106501

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiplatelet and anticoagulant ...... yndrome: where we are in 2013.

@en

type

Item

label

Antiplatelet and anticoagulant ...... yndrome: where we are in 2013.

@en

prefLabel

Antiplatelet and anticoagulant ...... yndrome: where we are in 2013.

@en

P1476

Antiplatelet and anticoagulant ...... yndrome: where we are in 2013.

@en

P2093

Matthew Lumley

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Bivalirudin for patients with acute coronary syndromes

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment

P304

371-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.13.21

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Divaka Perera

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23668742

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation